171 related articles for article (PubMed ID: 2230972)
1. Antigen related to cell proliferation in malignant gliomas recognized by a human monoclonal antibody.
Kokunai T; Tamaki N; Matsumoto S
J Neurosurg; 1990 Dec; 73(6):901-8. PubMed ID: 2230972
[TBL] [Abstract][Full Text] [Related]
2. [Monoclonal immunotherapy with human monoclonal antibody(CLN-IgG) in glioma patients].
Kubo O; Takakura K
Nihon Rinsho; 2002 Mar; 60(3):497-503. PubMed ID: 11904965
[TBL] [Abstract][Full Text] [Related]
3. Identification of a malignant cell associated antigen recognized by a human monoclonal antibody.
Aotsuka Y; Hagiwara H
Eur J Cancer Clin Oncol; 1988 May; 24(5):829-38. PubMed ID: 3049115
[TBL] [Abstract][Full Text] [Related]
4. Characterization of neuroectodermal antigen by a monoclonal antibody and its application in CSF diagnosis of human glioma.
Wakabayashi T; Yoshida J; Seo H; Kazo K; Murata Y; Matsui N; Kageyama N
J Neurosurg; 1988 Mar; 68(3):449-55. PubMed ID: 3343615
[TBL] [Abstract][Full Text] [Related]
5. Determination of the antigen/epitope that is recognized by human monoclonal antibody CLN-IgG.
Hagiwara H; Aotsuka Y; Yamamoto Y; Miyahara J; Mitoh Y
Hum Antibodies; 2001; 10(2):77-82. PubMed ID: 11673662
[TBL] [Abstract][Full Text] [Related]
6. [Anti-TA226 human monoclonal antibody (ACA-11) against glioma].
Kokunai T
Nihon Rinsho; 2002 Jan; 60(1):100-6. PubMed ID: 11808318
[TBL] [Abstract][Full Text] [Related]
7. Human glioma-mesenchymal extracellular matrix antigen defined by monoclonal antibody.
Bourdon MA; Wikstrand CJ; Furthmayr H; Matthews TJ; Bigner DD
Cancer Res; 1983 Jun; 43(6):2796-805. PubMed ID: 6342760
[TBL] [Abstract][Full Text] [Related]
8. Preferential expression and frequent IgG responses of a tumor antigen, SOX5, in glioma patients.
Ueda R; Yoshida K; Kawase T; Kawakami Y; Toda M
Int J Cancer; 2007 Apr; 120(8):1704-11. PubMed ID: 17230535
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal antibody-dependent, cell-mediated cytotoxicity against human malignant gliomas.
Takahashi H; Belser PH; Atkinson BF; Sela BA; Ross AH; Biegel J; Emanuel B; Sutton L; Koprowski H; Herlyn D
Neurosurgery; 1990 Jul; 27(1):97-102. PubMed ID: 1695996
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibodies in neuro-oncology.
Stavrou D
Neurosurg Rev; 1990; 13(1):7-18. PubMed ID: 2181345
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibodies with cytotoxic reactivities against human gliomas.
Nanda A; Liwnicz B; Atkinson BF; Sela BA; Takahashi H; Belser PH; Black P; Koprowski H; Herlyn D
J Neurosurg; 1989 Dec; 71(6):892-7. PubMed ID: 2585082
[TBL] [Abstract][Full Text] [Related]
12. Correlation of chondroitin sulfate proteoglycan expression on proliferating brain capillary endothelial cells with the malignant phenotype of astroglial cells.
Schrappe M; Klier FG; Spiro RC; Waltz TA; Reisfeld RA; Gladson CL
Cancer Res; 1991 Sep; 51(18):4986-93. PubMed ID: 1893386
[TBL] [Abstract][Full Text] [Related]
13. Human monoclonal antibody BT32/A6 and a cell cycle-independent glioma-associated surface antigen.
Dan MD; Earley EM; Griffin MC; Maiti PK; Prashar AK; Yuan XY; Friesen AD; Kaplan HA
J Neurosurg; 1995 Mar; 82(3):475-80. PubMed ID: 7861227
[TBL] [Abstract][Full Text] [Related]
14. Tumor localization of human brain malignant glioma xenograft in nude mice with a radiolabeled monoclonal antibody.
Lee WH; Yeh MY; Tu YC
Neurosurgery; 1990 Mar; 26(3):381-90. PubMed ID: 2320206
[TBL] [Abstract][Full Text] [Related]
15. Derivation of a brain tumor-selective monoclonal antibody from hybridoma between mouse myeloma and rat spleen cells immune to syngeneic glioma.
Saya H; Masuko T; Hashimoto Y
Jpn J Cancer Res; 1985 Dec; 76(12):1198-202. PubMed ID: 3937832
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibody 8H9 targets a novel cell surface antigen expressed by a wide spectrum of human solid tumors.
Modak S; Kramer K; Gultekin SH; Guo HF; Cheung NK
Cancer Res; 2001 May; 61(10):4048-54. PubMed ID: 11358824
[TBL] [Abstract][Full Text] [Related]
17. Detection of human glioma-associated antigen by rat monoclonal antibody raised against syngeneic rat glioma cells.
Saya H; Masuko T; Kokunai T; Yagita H; Ijichi A; Taomoto K; Tamaki N; Matsumoto S; Hashimoto Y
J Neurosurg; 1986 Oct; 65(4):495-502. PubMed ID: 3760959
[TBL] [Abstract][Full Text] [Related]
18. Pritumumab, the first therapeutic antibody for glioma patients.
Babic I; Nurmemmedov E; Yenugonda VM; Juarez T; Nomura N; Pingle SC; Glassy MC; Kesari S
Hum Antibodies; 2018 Feb; 26(2):95-101. PubMed ID: 29036806
[TBL] [Abstract][Full Text] [Related]
19. Antigenic heterogeneity of human brain tumors defined by monoclonal antibodies.
Stavrou D; Bise K; Groeneveld J; Stocker U; Kretzschmar HA; Keiditsch E; Mehraein P
Anticancer Res; 1989; 9(6):1489-96. PubMed ID: 2697177
[TBL] [Abstract][Full Text] [Related]
20. Identification of a human leukocyte antigen-A24-restricted T-cell epitope derived from interleukin-13 receptor alpha2 chain, a glioma-associated antigen.
Shimato S; Natsume A; Wakabayashi T; Tsujimura K; Nakahara N; Ishii J; Ito M; Akatsuka Y; Kuzushima K; Yoshida J
J Neurosurg; 2008 Jul; 109(1):117-22. PubMed ID: 18590440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]